Point72 Asset Management, L.P.

Position in TSHA — Taysha Gene Therapies, Inc.

CIK 1603466 STAMFORD, CT

Position in TSHA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$2,064,496

-$19,213,255 QoQ

Shares Held

461,856

-88.1% QoQ

Ownership

0.161%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2020

10 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Point72 Asset Management, L.P. holds $2,393,450,612 across 188 Biotechnology names. TSHA ranks #103 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	APLS	Apellis Pharmaceuticals, Inc.	4,183,918	$168,319,021
2	MDGL	Madrigal Pharmaceuticals, Inc.	225,510	$118,047,719
3	CLDX	Celldex Therapeutics, Inc.	3,229,939	$102,453,665
4	RYTM	Rhythm Pharmaceuticals, Inc.	846,801	$73,646,282
5	AXSM	Axsome Therapeutics, Inc.	424,750	$71,791,245
6	ABVX	Abivax S.A.	637,736	$71,011,903
7	LEGN	Legend Biotech Corp	3,886,017	$70,298,047
8	JAZZ	Jazz Pharmaceuticals plc	358,634	$67,799,757

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,064,496	461,856	-88.1%	Shares	Defined	2026-05-15
2025-12-31	$21,277,751	3,868,682	-47.2%	Shares	Defined	2026-02-17
2025-09-30	$23,973,906	7,331,470	+0.2%	Shares	Defined	2025-11-14
2025-06-30	$16,903,688	7,317,614	+60.1%	Shares	Defined	2025-08-14
2025-03-31	$6,351,852	4,569,678	+310.5%	Shares	Defined	2025-07-21
2024-03-31	$3,194,975	1,113,232	-58.6%	Shares	Defined	2024-05-15
2023-12-31	$4,757,760	2,688,000	+187.0%	Shares	Defined	2024-02-14
2023-09-30	$2,959,498	936,550	+6907.0%	Shares	Defined	2023-11-14
2020-12-31	$354,733	13,366	-93.3%	Shares	Defined	2021-02-16
2020-09-30	$4,480,000	200,000	—	Shares	Defined	2020-11-16
No filing history on record for this holder in this stock.